DDI-DrugBank.d627.s0 >> Pilocarpine should be administered with caution to patients taking beta adrenergic antagonists because of the possibility of conduction disturbances. >> 0-10,67-93
DDI-DrugBank.d627.s1 >> Drugs with parasympathomimetic effects administered concurrently with pilocarpine would be expected to result in additive pharmacologic effects. >> 70-80
DDI-DrugBank.d627.s2 >> Pilocarpine might antagonize the anticholinergic effects of drugs used concomitantly. >> 0-10
DDI-DrugBank.d627.s3 >> These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g., atropine, inhaled ipratropium). >> 146-153,164-174
DDI-DrugBank.d627.s4 >> While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone. >> 179-198,219-225,228-247,250-275,278-286,289-308,311-337,340-351,354-366,369-376,379-388,391-401,408-417
